Literature DB >> 10170087

A note on prevention versus cure.

M Johannesson1, P O Johansson.   

Abstract

The aim of this study is to test if the general Swedish population prefers saving lives through prevention or acute care. A trade-off question of a choice between saving lives through prevention or acute care was administered in a Swedish population sample. Based on the answers we estimate the median number of lives saved in acute care that is judged equivalent to saving one life through prevention. According to the results 1.2-1.4 lives saved in acute care is judged equivalent to saving one life through prevention. Thus our results indicate that lives saved through prevention and cure are given about the same value by the median respondent. Individuals seem to focus on the size of the health benefits rather than whether the health benefits are achieved through prevention or cure.

Mesh:

Year:  1997        PMID: 10170087     DOI: 10.1016/s0168-8510(97)00020-1

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  4 in total

Review 1.  Resource allocation, social values and the QALY: a review of the debate and empirical evidence.

Authors:  David L B Schwappach
Journal:  Health Expect       Date:  2002-09       Impact factor: 3.377

Review 2.  Willingness to pay for a QALY: theoretical and methodological issues.

Authors:  Dorte Gyrd-Hansen
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  The equivalence of numbers: the social value of avoiding health decline: an experimental Web-based study.

Authors:  David L B Schwappach
Journal:  BMC Med Inform Decis Mak       Date:  2002-03-05       Impact factor: 2.796

4.  Prevention praised, cure preferred: results of between-subjects experimental studies comparing (monetary) appreciation for preventive and curative interventions.

Authors:  Ree M Meertens; Vivian M J Van de Gaar; Maitta Spronken; Nanne K de Vries
Journal:  BMC Med Inform Decis Mak       Date:  2013-12-18       Impact factor: 2.796

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.